80 related articles for article (PubMed ID: 8999328)
1. More on pravastatin and coronary disease.
Grundy SM
N Engl J Med; 1996 Oct; 335(16):1239-40. PubMed ID: 8999328
[No Abstract] [Full Text] [Related]
2. Prevention of coronary heart disease with pravastatin.
Rogers S
N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
[No Abstract] [Full Text] [Related]
3. Cost effectiveness of coronary prevention.
Szucs TD; März W
Eur Heart J; 1999 Feb; 20(4):317-8. PubMed ID: 10099929
[No Abstract] [Full Text] [Related]
4. Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
Ito MK; Shabetai R
Am J Cardiol; 1997 Sep; 80(6):799-802. PubMed ID: 9315597
[TBL] [Abstract][Full Text] [Related]
5. [Victory in primary prevention--or? Can we afford to translate results from the West-of-Scotland Study into general practice?].
Klose G
Fortschr Med; 1996 Jun; 114(17):231-2. PubMed ID: 8767302
[No Abstract] [Full Text] [Related]
6. [Pharmaco-economic aspects of hypolipidemic treatment].
Scheen AJ
Rev Med Liege; 1997; 52(1):16-21. PubMed ID: 9064710
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
Tsevat J; Kuntz KM; Orav EJ; Weinstein MC; Sacks FM; Goldman L
Am Heart J; 2001 May; 141(5):727-34. PubMed ID: 11320359
[TBL] [Abstract][Full Text] [Related]
8. The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.
Caro J; Klittich W; McGuire A; Ford I; Norrie J; Pettitt D; McMurray J; Shepherd J
BMJ; 1997 Dec; 315(7122):1577-82. PubMed ID: 9437275
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention.
Am J Manag Care; 1998 Apr; 4(4 Suppl):S185-90. PubMed ID: 10184933
[No Abstract] [Full Text] [Related]
10. Pravastatin and coronary heart disease.
Bloom JM
N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
[No Abstract] [Full Text] [Related]
11. Prevention of coronary heart disease with pravastatin.
Samani NJ; de Bono DP
N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model.
Muls E; Van Ganse E; Closon MC
Atherosclerosis; 1998 Apr; 137 Suppl():S111-6. PubMed ID: 9694550
[TBL] [Abstract][Full Text] [Related]
13. Prevention of coronary heart disease with pravastatin.
Davis DR
N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
[No Abstract] [Full Text] [Related]
14. By the way, doctor. I have high cholesterol, and have been taking Mevacor (lovastatin) for two years. Recently, I was switched to Pravachol (pravastatin) because my insurance company would no longer pay for Mevacor. Is it as good?
Nicholson CR
Harv Womens Health Watch; 1999 Jun; 6(10):8. PubMed ID: 10233830
[No Abstract] [Full Text] [Related]
15. [Economic aspects of drug therapy exemplified by pravastatin. A socioeconomic analysis of cholesterol synthase enzyme inhibition in coronary heart disease patients].
Berger K; Klose G; Szucs TD
Med Klin (Munich); 1997 Jun; 92(6):363-9. PubMed ID: 9297070
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention of coronary artery disease.
Domanski MJ
N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
[No Abstract] [Full Text] [Related]
18. Pharmaco-economic assessment of the HMG-CoA reductase inhibitors.
Smart AJ; Walters L
S Afr Med J; 1994 Dec; 84(12):834-7. PubMed ID: 7570232
[TBL] [Abstract][Full Text] [Related]
19. Lowering cholesterol with drugs and diet.
Pedersen TR
N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029
[No Abstract] [Full Text] [Related]
20. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
